Ofev – Nintedanib uses, dose and side effects
Ofev contains the active substance nintedanib, a drug belonging to the group of so-called tyrosine kinase inhibitors, and is used to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrotizing interstitial lung diseases (ILDs) that are exacerbated (with progressive disease progression) and systemic sclerosis-systemic sclerosis. lung disease (SSc-ILD) in adults.
Read More